Abstract
Helicobacter pylori is, probably, the most common bacterial infection in the world with a worldwide prevalence rate of 40-50%. In most cases is asymptomatic, but in some cases is associated with peptic ulcer, gastric adenocarcinoma, gastric MALT lymphoma, or dyspepsia. Effective H. pylori eradication therapy allows the complete healing of peptic ulcer, and the elimination of a key cofactor in the appearance of gastric adenocarcinoma and lymphoma. The following protocol includes currently accepted diagnosis methodology, treatment indications and the appropriate therapeutic regimens for the eradication of bacteria as related as acknowledged in recent guidelines
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Medicine - Programa de Formación Médica Continuada acreditado
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
